The collaboration will place an emphasis on targeted populations living with hypertension in Illinois, Kentucky, Michigan and ...
CVS Health reported $2.9 billion in fourth quarter net income as the company begins to get a handle on costs that have hit ...
A new sign with orange letters outside a former Rite Aid in Germantown announces the arrival of a primary care model new to ...
CVS' Q4 2025 saw record revenue, but rising medical costs in Aetna drove a $1B cut to FY 2026 cash flow guidance, now at $9B.
Aetna members in California can now access the MD-03 Protocol™ at lower monthly costs, making personalized skin health ...
The results signal steady progress in the health-care giant's aggressive turnaround plan under CEO David Joyner, who stepped into the role in late 2024.
Medications such as Wegovy and Zepbound will no longer be covered for weight loss, although GLP-1 drugs for diabetes will still be approved.
Some payments that were originally expected in early 2026 instead arrived late in 2025, boosting reported 2025 cash flow but reducing 2026’s starting point. As a result, CVS now guides to at least $9 ...
CVS Health's workforce reduction follows a broader pattern of retrenchment across the health insurance sector. Horizon Blue ...
People gathered to raise a Pride flag at the Stonewall National Monument in New York City Thursday, after the Park Service removed a flag on Tuesday.
Your doctor submits a claim to your health insurance. The claim is denied. You might be justified in thinking the denial is ...
CVS Health CEO David Joyner told investors on Tuesday that the recently proposed rates for the 2027 Medicare Advantage plan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results